Bio-Cancer Treatment International Ltd - Company Review
SummaryBio-Cancer Treatment International Ltd - Company Review
Summary
Bio-Cancer Treatment International Ltd (BCT) is a biopharmaceutical company that offers research and development of biologics. The company’s products include BCT-100 and BCT-200. Its BCT-100 includes pegylated recombinant human arginase being developed for arginine depletion therapy in arginine auxotrophic cancers. BCT’s BCT-200 is a modification of BCT-100 with alterations to the amino acid sequence being developed for arginine depletion therapy in autoimmune disorders and other potential indications. The company conducts clinical trials and research and development of novel biologics for the treatment of human malignancies and immune disorders. It has its presence in Shanghai and Hong Kong. BCT is headquartered in Hong Kong.
This comprehensive company report of Bio-Cancer Treatment International Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.